BGLCNasdaqServices-Medical LaboratoriesFiscal year ends December 31
BioNexus Gene Lab Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.23+0.03 (+2.23%)
Close on Oct 19, 2026
- Market cap
- $2.97M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of BioNexus Gene Lab's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 5, 2026 | Oct 7, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 28, 2026 | Jul 28, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Apr 14, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 11, 2026 | Mar 17, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 23, 2026 | Feb 23, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 28, 2026 | Feb 3, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 24, 2025 | Dec 30, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 19, 2025 | Dec 23, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 24, 2025 | Dec 3, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 28, 2025 | Dec 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 7, 2025 | Nov 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 20, 2025 | Oct 23, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 18, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 30, 2025 | Jul 30, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2025 | Jun 23, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2025 | Apr 30, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 29, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 7, 2025 | Apr 10, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 1, 2025 | Apr 3, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 19, 2025 | Mar 25, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 7, 2025 | Mar 7, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 5, 2025 | Mar 5, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Mar 19, 2025 | Feb 27, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 11, 2025 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 27, 2024 | Jan 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 15, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 5, 2024 | Nov 8, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2024 | Oct 15, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 4, 2024 | Oct 10, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 23, 2024 | Sep 25, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 14, 2024 | Sep 18, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 4, 2024 | Sep 16, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 11, 2024 | Sep 12, 2024 | SEC EDGAR |